Rift Valley Fever Virus (RVFV) is an arbovirus responsible for significant mortality and morbidity in both humans and animals. Classified by the WHO as a priority pathogen, RVFV is at risk of worldwide emergence notably due to a large vector species spectrum. As other arboviruses, RVFV vector competence (VC) is driven by genetic and environmental factors. Understand how these factors shape RVFV transmission by mosquitoes is therefore critical to mitigate Rift Valley fever emergence and spread. Conversely to dengue, chikungunya or Zika viruses, little is known on the impact of major VC drivers such as mosquitoes species or virus dose for RVFV. In addition, some potential VC drivers have been overlooked for most arboviruses, such as the cellular origin of viruses used in VC assays. Finally, intra-vector infection dynamics (DIV), represented by the distribution of extrinsic incubation period (EIP) within the mosquito population, remains a black box for many vector-arbovirus pairs. Here, we solved some of these gaps by feeding Aedes aegypti and Culex quinquefasciatus mosquitoes with the RVFV ZH548 reference strain prior to detect, at various time post RVFV exposure, infectious virus in mosquito tissues representative of infection, dissemination and transmission stages. These data were then used to model RVFV DIV for both mosquito species. Major VC variations were observed according to mosquito species, virus dose and cell line used for virus stock production, in a stage-specific manner. Furthermore, key differences were unveiled between the DIV of Ae. aegypti and Cx . quinquefasciatus mosquitoes. This study highlights the pattern of RVFV dynamics in mosquitoes according to major VC drivers, and provides a reference data set upon standardized experimental VC assay in two major RVFV vector genera ( Aedes and Culex ). Altogether, this work opens new avenues towards the understanding RVFV-mosquito interactions, and how they can modulate RVFV emergence and spread. AUTHOR SUMMARY Rift valley fever virus (RVFV) is an understudied but threatening mosquito-borne pathogen, both from human and animal health perspective. The limited number of studies, notably on mosquito capacity to transmit this virus (vector competence), prevents us to fully understand RVFV epidemiology and mitigate emergence. Here, I explored key aspects of RVFV transmission by exposing mosquitoes to a reference virus strain through an artificial blood meal. Results show that the mosquito species, the dose of virus in the blood meal or the way the virus is prepared prior to add it into the blood meal impact vector competence. Each factor above displays stage-specific impact on RVFV-mosquito interaction, modulating either initial mosquito infection, virus dissemination within the mosquito cavity or virus spread in vector’s saliva. Finally, modeling tools applied to vector competence data showed that each mosquito species present a specific balance between susceptibility (% of mosquitoes infected) and time to infectiousness (median number of days to switch from infected to disseminated stage). Altogether, this work uncovers key features of mosquito vector competence for RVFV, explains previous literature discrepancies and highlights the benefit of combining experimental and modeling work to link vector competence and epidemiological studies.